Table 1.
Microbes’ effects in Parkinson’s Disease.
| Phylum | Genus | Change | Effects on Parkinson’s Pathophysiology | References |
|---|---|---|---|---|
| Bacteroidetes | Prevotella | Reduced | Reduced secretion of neuroprotective hydrogen sulfide into the gut lumen and decreased intestinal motility | [117,118,121,125] |
| Bacteroides | Reduced | [119,126] | ||
| Firmicutes | Lactobacillus | Reduced | Less neuroprotective effects, unable to rescue dopaminergic neuron loss, Inability to downregulate MAO-B, Reduced BDNF and tyrosine hydroxylase expression |
[34,97,119,121] |
| Lactobacillus | Elevated | Deconjugates neuroprotective bile acids, TDCA and UDCA | [118,124,127,128] | |
| Clostridium | Reduced | Increased α-synuclein accumulation | [117,124,128,129] | |
| Enterococcus | Elevated | [122] | ||
| Ruminococcus | Elevated | Ruminococcus Albus reduces ROS species, increases BDNF effects, and has associations with decreased neuroprotective bile acids | [120,121,127,130] | |
| Actinobacteria | Bifidobacterium | Elevated | Confers neuroprotective effects on dopaminergic neuron loss | [97,121] |
| Verrucomicrobia | Akkermansia | Elevated | Mucin-degrading genus, increases LPS and microglial activity | [116,117,118,131] |